Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?

Affiliations

• ¹ Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
• ² Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, USA.
• ³ Harvard Medical School, Boston, MA, USA.
• ⁴ Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR, USA.
• ⁵ Section of Cardiology, Birmingham Veterans Affair Medical Center, Birmingham, AL, USA.
• ⁶ Division of Molecular Imaging and Therapeutics, Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.